Toxic Alcohol Poisoning (Methanol & Ethylene Glycol)

Topic Overview

Summary

Toxic alcohol poisoning encompasses the ingestion of methanol and ethylene glycol, two substances that undergo hepatic metabolism via alcohol dehydrogenase to produce highly toxic organic acid metabolites. Methanol is converted to formic acid, which causes retinal toxicity and optic neuropathy leading to permanent blindness, while ethylene glycol is metabolized to glycolic and oxalic acids, resulting in severe nephrotoxicity and acute kidney injury. Both toxic alcohols produce a characteristic biphasic clinical presentation with initial inebriation followed by profound high anion gap metabolic acidosis. Early recognition is critical, as timely administration of fomepizole (or ethanol) to competitively inhibit alcohol dehydrogenase, combined with extracorporeal removal via hemodialysis in severe cases, can prevent irreversible end-organ damage and mortality. [1,2,3]

Key Facts

• Methanol: Metabolized to formaldehyde and formic acid → mitochondrial cytochrome oxidase inhibition → optic nerve damage and blindness
• Ethylene glycol: Metabolized to glycoaldehyde, glycolic acid, glyoxylic acid, and oxalic acid → acute tubular necrosis and calcium oxalate crystal deposition
• Presentation: Biphasic with early inebriation (0-12 hours) followed by metabolic acidosis and end-organ toxicity (12-24+ hours)
• Diagnostic clues: Osmolar gap (early phase, parent compound present), anion gap (late phase, toxic metabolites accumulated)
• Treatment pillars: Fomepizole (alcohol dehydrogenase inhibitor) + hemodialysis (removes parent compound and metabolites) + supportive care
• Prognostic factors: Time to treatment, severity of acidosis (pH less than 7.0 associated with high mortality), presence of end-organ damage at presentation [4,5]

Clinical Pearls

Temporal evolution of gaps: Early presentation = elevated osmolar gap (parent compound); Late presentation = elevated anion gap (toxic metabolites). Both gaps may coexist during metabolic transition phase.

"Blind drunk" mnemonic: Methanol poisoning causes visual disturbances (optic neuropathy) — any visual complaint in suspected toxic ingestion mandates immediate treatment.

Envelope and needle crystals: Calcium oxalate crystals in urine (monohydrate = envelope-shaped; dihydrate = needle-shaped) are pathognomonic for ethylene glycol but only present in 50% of cases. [6]

"No gap, no problem" is FALSE: Normal osmolar gap does NOT exclude toxic alcohol poisoning, especially if presentation is delayed (parent compound already metabolized). Rely on clinical suspicion and anion gap metabolic acidosis.

Wood's lamp fluorescence: Some antifreeze products contain fluorescein dye; urine may fluoresce under ultraviolet light, though this finding is neither sensitive nor specific.

Why This Matters Clinically

Toxic alcohol poisoning, while relatively uncommon, represents a true medical emergency with mortality rates of 20-40% in untreated cases and catastrophic morbidity in survivors, including permanent blindness and end-stage renal disease. [7] The window for intervention is narrow — formic acid and glycolic acid accumulation causes irreversible tissue damage within hours. Emergency physicians and intensivists must maintain high clinical suspicion based on history (ingestion, alcohol substitution, contaminated spirits), unexplained high anion gap metabolic acidosis with osmolar gap, and characteristic clinical features. Early empirical treatment with fomepizole can be life-saving and vision-saving, even before confirmatory toxic alcohol levels return from the laboratory. This condition exemplifies the principle of "treat first, confirm later" in toxicology. [8,9]

---

Visual Summary

Visual assets to be added:

• Toxic alcohol metabolism pathway (alcohol dehydrogenase pathway showing methanol → formaldehyde → formic acid and ethylene glycol → glycoaldehyde → glycolic acid → oxalic acid)
• Osmolar gap vs anion gap timeline (temporal evolution showing early osmolar gap transitioning to late anion gap)
• Calcium oxalate crystals microscopy (envelope-shaped monohydrate and needle-shaped dihydrate)
• Fomepizole mechanism of action (competitive inhibition of alcohol dehydrogenase)
• Toxic alcohol management algorithm (decision tree from presentation to antidote and hemodialysis indications)
• Fundoscopic findings in methanol toxicity (optic disc hyperemia, retinal edema)

---

Epidemiology

Incidence and Prevalence

Toxic alcohol poisoning is an uncommon but consistently fatal condition when untreated. Precise incidence data are limited due to underreporting and misdiagnosis, but estimated rates in developed countries range from 0.5-1.5 cases per 100,000 population annually. [10] Mass poisoning outbreaks occur sporadically worldwide, particularly in low- and middle-income countries where methanol-contaminated illicit or counterfeit alcohol causes epidemic poisoning events with case-fatality rates of 20-30%. Recent outbreaks in Iran, India, Turkey, and Indonesia have resulted in hundreds of deaths. [11]

Demographics and Risk Groups

Adults at high risk:

• Chronic alcohol use disorder: Individuals drinking methanol-containing products (industrial solvents, antifreeze, fuel) as ethanol substitutes
• Intentional self-harm: Deliberate ingestion in suicide attempts
• Occupational exposure: Workers in industrial settings (painters, printers, automotive repair) with access to solvents
• Social and economic deprivation: Consumption of inexpensive methanol-contaminated spirits

Pediatric cases:

• Accidental ingestion: Young children attracted to sweet-tasting ethylene glycol in antifreeze (flavoring agents)
• Exploratory ingestion: Toddlers accessing automotive or household products

Other vulnerable populations:

• Elderly with dementia: Confusion leading to accidental consumption
• Prison inmates: Consumption of illicitly produced alcohol
• Homeless individuals: Drinking surrogate alcohol sources

Geographic Variations

• High-income countries: Sporadic cases, predominantly individual ingestions (suicide attempts, accidental exposure)
• Low- and middle-income countries: Epidemic outbreaks from methanol-adulterated spirits, particularly during festivals or periods of alcohol prohibition
• Seasonal patterns: Increased ethylene glycol poisoning in winter months (antifreeze exposure) and methanol poisoning during religious festivals when illicit alcohol consumption rises

Sources of Exposure

Mortality and Morbidity

• Methanol: Mortality 8-30% depending on time to treatment; 25-33% of survivors develop permanent visual impairment or blindness. [12]
• Ethylene glycol: Mortality 1-22% with treatment; acute kidney injury occurs in 20-50%, with 10-20% requiring long-term dialysis. [13]
• Prognostic indicators: Presenting pH less than 7.0, delay to treatment > 24 hours, presence of end-organ damage (visual symptoms, anuria), serum levels > 50 mg/dL

---

Pathophysiology

Molecular and Cellular Mechanisms

Methanol Metabolism and Toxicity

Methanol (CH₃OH) is a simple one-carbon alcohol rapidly absorbed from the gastrointestinal tract, reaching peak serum concentrations within 30-90 minutes of ingestion. The volume of distribution is 0.6-0.7 L/kg, with rapid distribution to total body water. [14]

Metabolic pathway:

1. Alcohol dehydrogenase (ADH) oxidation: Methanol undergoes hepatic oxidation by alcohol dehydrogenase (predominantly ADH1) to formaldehyde (CH₂O). This is the rate-limiting step and has a half-life of approximately 14-20 hours without treatment (extends to 30-50 hours with fomepizole). [15]

2. Aldehyde dehydrogenase (ALDH) oxidation: Formaldehyde is rapidly converted by aldehyde dehydrogenase (mitochondrial ALDH2) to formic acid (HCOOH), the principal toxic metabolite.

3. Formic acid accumulation: Formate is metabolized slowly via a folate-dependent pathway (10-formyltetrahydrofolate synthetase) to carbon dioxide and water. Saturation of this pathway leads to formate accumulation.

Mechanisms of toxicity:

• Mitochondrial toxicity: Formic acid is a potent inhibitor of mitochondrial cytochrome c oxidase (complex IV of the electron transport chain), causing histotoxic hypoxia and impaired cellular respiration. This particularly affects high-energy-demand tissues (retina, basal ganglia, white matter). [16]

• Retinal toxicity: The retina is uniquely vulnerable due to high metabolic activity and poor formate clearance. Formic acid causes photoreceptor dysfunction, retinal ganglion cell death, and retrolaminar optic nerve demyelination, leading to optic atrophy and permanent vision loss.

• Metabolic acidosis: Accumulation of formic acid (pKa 3.75) generates profound metabolic acidosis with anion gap elevation. Concurrent lactate accumulation occurs secondary to cellular hypoxia.

• Basal ganglia injury: Putaminal necrosis and hemorrhage occur in severe cases, leading to parkinsonism (extrapyramidal symptoms persisting after recovery).

Lethal dose: Estimated at 1-2 mL/kg (0.3-1 g/kg) in adults; as little as 10 mL can cause blindness, 30 mL can be fatal. [17]

Ethylene Glycol Metabolism and Toxicity

Ethylene glycol (C₂H₆O₂) is a two-carbon diol also rapidly absorbed from the gastrointestinal tract with near-complete bioavailability. Volume of distribution is 0.5-0.8 L/kg. [18]

Metabolic pathway (sequential oxidation):

1. Ethylene glycol → Glycoaldehyde: Alcohol dehydrogenase catalyzes conversion (rate-limiting step). Half-life of ethylene glycol is 3-8 hours without treatment (extends to 17-20 hours with fomepizole). [19]

2. Glycoaldehyde → Glycolic acid: Aldehyde dehydrogenase oxidation. Glycolic acid is the primary metabolite responsible for acidosis and organ toxicity.

3. Glycolic acid → Glyoxylic acid: Glycolic acid oxidase and lactate dehydrogenase convert glycolic acid to glyoxylic acid.

4. Glyoxylic acid → Oxalic acid: Terminal metabolite, binds calcium to form calcium oxalate crystals.

Mechanisms of toxicity:

• Metabolic acidosis: Glycolic acid accumulation is the predominant cause of severe high anion gap metabolic acidosis (glycolic acid contributes 60-70% of the acidosis).

• Nephrotoxicity: Calcium oxalate crystal deposition in renal tubules causes acute tubular necrosis, tubular obstruction, and inflammatory injury. Both monohydrate (envelope-shaped) and dihydrate (needle-shaped, prismatic) crystals form in proximal and distal tubules. [20]

• Hypocalcemia: Calcium chelation by oxalate leads to ionized hypocalcemia, causing QT prolongation, arrhythmias, tetany, and seizures.

• Cerebral and pulmonary toxicity: Calcium oxalate crystal deposition in brain (cerebral edema) and lungs (pulmonary hemorrhage and edema) contributes to morbidity.

• Direct cellular toxicity: Glycolic acid impairs cellular respiration and causes oxidative stress independent of acidosis.

Lethal dose: Estimated at 1-1.5 mL/kg (approximately 100 mL in adults can be fatal). [21]

Three-Phase Clinical Course

Phase I (0-12 hours): Inebriation phase

• Parent compound (methanol/ethylene glycol) exerts CNS depressant effects
• Elevated osmolar gap (unmeasured osmoles present)
• Minimal or absent metabolic acidosis

Phase II (12-24 hours): Metabolic acidosis phase

• Parent compound metabolized to toxic acids
• High anion gap metabolic acidosis develops
• Osmolar gap normalizes as parent compound depleted
• Compensatory hyperventilation (Kussmaul breathing)

Phase III (24-72 hours): End-organ toxicity phase

• Methanol: Visual symptoms, optic neuropathy, basal ganglia necrosis
• Ethylene glycol: Acute kidney injury, oliguria/anuria, calcium oxalate crystalluria

Osmolar and Anion Gap Dynamics

Osmolar gap = Measured serum osmolality - Calculated osmolality

Calculated osmolality = 2(Na) + (Glucose/18) + (BUN/2.8) + (Ethanol/4.6)
(All units in mg/dL except Na in mmol/L; result in mOsm/kg)

• Normal osmolar gap: -10 to +10 mOsm/kg
• Osmolar gap > 10 suggests presence of unmeasured osmoles (toxic alcohols, ketones, mannitol)
• Each 10 mg/dL of methanol or ethylene glycol increases osmolar gap by ~1-2 mOsm/kg

Limitations of osmolar gap:

• Sensitivity 73-87%, specificity 92-94% for toxic alcohols [22]
• Normal gap does NOT exclude poisoning (late presentation, concurrent ethanol ingestion dilutes gap)
• False positives: ketones, lactate, ethanol, isopropanol, mannitol, contrast media

Anion gap = Na - (Cl + HCO₃)

• Normal: 8-12 mmol/L (may vary by laboratory)
• Elevated in toxic alcohol poisoning due to formic acid (methanol) or glycolic acid (ethylene glycol)
• Anion gap > 20 mmol/L suggests severe poisoning requiring aggressive treatment

MUDPILES mnemonic for high anion gap metabolic acidosis:

• Methanol
• Uremia
• Diabetic ketoacidosis
• Paraldehyde, Propylene glycol
• Isoniazid, Iron
• Lactic acidosis
• Ethylene glycol
• Salicylates

---

Clinical Presentation

Early Phase (0-12 Hours): Intoxication

Neurological:

• Inebriation mimicking ethanol intoxication (ataxia, dysarthria, euphoria)
• Drowsiness, lethargy
• Headache
• Confusion

Gastrointestinal:

• Nausea and vomiting (occur in 40-60% of cases)
• Abdominal pain (less common)
• Epigastric discomfort

Cardiovascular:

• Tachycardia (mild)
• Normal blood pressure or mild hypotension

Metabolic:

• No acidosis or minimal acidosis (parent compound not yet metabolized)
• Elevated osmolar gap

Key diagnostic challenge: Patients may appear only mildly symptomatic, leading to premature discharge if toxic alcohol ingestion not suspected.

Late Phase (12-24+ Hours): Metabolic Acidosis and End-Organ Toxicity

Methanol-Specific Features

Visual disturbances (occur in 50% of symptomatic patients): [23]

• Blurred vision ("like looking through a snowstorm")
• Photophobia
• Decreased visual acuity
• Central scotomas (blind spots)
• Complete blindness (bilateral in severe cases)
• Color vision defects

Ophthalmologic findings:

• Dilated, sluggish, or non-reactive pupils
• Optic disc hyperemia (early sign within 24-48 hours)
• Optic disc edema
• Retinal edema and exudates
• Optic atrophy (late finding in survivors)

Neurological:

• Severe headache
• Altered mental status (confusion, delirium, coma)
• Seizures (usually late and related to severe acidosis or cerebral edema)
• Parkinsonism (basal ganglia necrosis): rigidity, bradykinesia, tremor (may be delayed by weeks)

Metabolic:

• Profound high anion gap metabolic acidosis (pH may be less than 7.0)
• Compensatory tachypnea (Kussmaul breathing)
• Anion gap typically 25-40 mmol/L

Cardiovascular:

• Tachycardia
• Hypotension (severe acidosis impairs cardiac contractility)
• Arrhythmias

Ethylene Glycol-Specific Features

Renal manifestations (occur in 20-50%): [24]

• Flank pain (from acute tubular necrosis and crystal deposition)
• Oliguria progressing to anuria
• Acute kidney injury (elevated creatinine, often requiring dialysis)
• Hematuria (microscopic or gross)
• Proteinuria

Urinalysis findings:

• Calcium oxalate crystals: envelope-shaped (monohydrate) or needle-shaped (dihydrate) — pathognomonic but present in only 30-50% of cases
• Hematuria
• Pyuria
• Low specific gravity (tubular dysfunction)

Neurological:

• Altered mental status (confusion, lethargy, coma)
• Seizures (from hypocalcemia or cerebral edema)
• Cranial nerve palsies (rare)
• Cerebral edema

Cardiovascular:

• Tachycardia
• Hypotension
• Arrhythmias (secondary to acidosis and hypocalcemia)
• Heart failure (calcium oxalate deposition in myocardium)

Hypocalcemia-related symptoms:

• Tetany (carpopedal spasm)
• Paresthesias
• QT prolongation on ECG
• Torsades de pointes
• Muscle cramps

Pulmonary:

• Tachypnea (Kussmaul breathing from acidosis)
• Pulmonary edema (non-cardiogenic, from calcium oxalate in pulmonary vessels)
• Adult respiratory distress syndrome (ARDS)

Red Flags Requiring Immediate Intervention

---

Clinical Examination

General Appearance

• Level of consciousness: Alert, drowsy, confused, or comatose (Glasgow Coma Scale assessment)
• Respiratory pattern: Tachypnea, Kussmaul breathing (deep, labored breathing indicating metabolic acidosis)
• Signs of intoxication: Ataxia, dysarthria, nystagmus

Vital Signs

• Heart rate: Tachycardia (compensatory response to acidosis and tissue hypoxia)
• Blood pressure: Normal, hypotension (severe acidosis), or hypertension (less common)
• Respiratory rate: Tachypnea (compensatory respiratory alkalosis attempting to correct metabolic acidosis)
• Temperature: Usually normal; hypothermia may occur in severe cases
• Oxygen saturation: Usually normal (metabolic acidosis, not respiratory compromise, unless pulmonary edema present)

Neurological Examination

• Orientation: Time, place, person
• Confusion, delirium
• Coma (Glasgow Coma Scale less than 8 indicates need for airway protection)

Cranial nerves:

• CN II (optic nerve): Visual acuity testing (Snellen chart or finger counting), visual fields (confrontation testing), pupillary responses (direct and consensual light reflexes)
• Fundoscopy: Optic disc hyperemia (early methanol), optic disc pallor (late), retinal edema, papilledema

Motor examination:

• Tone: Normal or increased (parkinsonism in methanol toxicity)
• Power: Usually normal unless severe systemic toxicity
• Extrapyramidal signs: Bradykinesia, rigidity, tremor (basal ganglia injury from methanol)

Reflexes:

• Hypocalcemia (ethylene glycol): Hyperreflexia, Chvostek sign (facial twitching with tapping facial nerve), Trousseau sign (carpopedal spasm with blood pressure cuff inflation)

Ophthalmologic Examination (Methanol)

Visual acuity:

• Formally assess each eye (Snellen chart, counting fingers, hand movements, light perception)
• Document degree of impairment

Pupillary examination:

• Size: May be dilated (mydriasis)
• Reactivity: Sluggish or absent light reflex indicates optic nerve dysfunction
• Relative afferent pupillary defect (RAPD / Marcus Gunn pupil): Swinging flashlight test positive in asymmetric optic nerve injury

Fundoscopy (direct ophthalmoscopy):

• Optic disc hyperemia (redness, "cherry red disc") — early sign within 24-48 hours, high specificity for methanol
• Optic disc edema (papilledema)
• Retinal edema (cloudy, whitish appearance)
• Retinal hemorrhages (less common)
• Optic atrophy (late finding): Pale optic disc

Cardiovascular Examination

• Tachycardia
• Hypotension (poor peripheral perfusion, delayed capillary refill)
• Arrhythmias (auscultate for irregular rhythm; ECG required for confirmation)
• Signs of heart failure: Elevated JVP, pulmonary crackles, peripheral edema (rare, but possible with myocardial calcium oxalate deposition)

Respiratory Examination

• Tachypnea with deep respirations (Kussmaul breathing)
• Pulmonary edema: Bilateral crackles, reduced air entry (ethylene glycol)
• Hypoxemia (pulse oximetry may be normal despite metabolic acidosis)

Abdominal Examination

• Epigastric tenderness (nonspecific)
• Flank tenderness (costovertebral angle tenderness suggests renal involvement in ethylene glycol)
• Bowel sounds usually normal

Additional Examination Findings

• Skin: Diaphoresis (sweating), pallor
• Odor: Methanol and ethylene glycol are odorless; concurrent ethanol ingestion may cause alcohol odor
• Hydration status: Assess mucous membranes, skin turgor (vomiting may cause dehydration)
• Neuropsychiatric: Assess for signs of chronic alcohol use (spider nevi, palmar erythema, hepatomegaly), which may suggest surrogate alcohol ingestion

---

Investigations

Blood Tests

Anion Gap Calculation and Interpretation

Formula:
Anion Gap (AG) = Na⁺ - (Cl⁻ + HCO₃⁻)

Normal range: 8-12 mmol/L (varies by laboratory; some use 3-11 mmol/L)

Correction for albumin (if hypoalbuminemia present):
Corrected AG = Calculated AG + 2.5 × (4.0 - measured albumin in g/dL)

Interpretation:

• AG 12-20: Mild elevation (early toxic alcohol poisoning, mixed disorders)
• AG 20-30: Moderate elevation (significant toxic acid accumulation)
• AG > 30: Severe elevation (life-threatening poisoning, requires urgent hemodialysis)

Delta-delta ratio (assess for mixed acid-base disorders):
Δ-Δ = (AG - 12) / (24 - HCO₃⁻)

• Ratio 1-2: Pure anion gap acidosis
• Ratio less than 1: Concurrent non-anion gap acidosis
• Ratio > 2: Concurrent metabolic alkalosis

Osmolar Gap Calculation and Interpretation

Formula:
Osmolar Gap = Measured serum osmolality - Calculated osmolality

Calculated osmolality (common formula):
2 × Na (mmol/L) + Glucose (mg/dL)/18 + BUN (mg/dL)/2.8 + Ethanol (mg/dL)/4.6

(Alternative SI units: 2 × Na + Glucose (mmol/L) + Urea (mmol/L) + Ethanol (mmol/L)/1.25)

Normal osmolar gap: -10 to +10 mOsm/kg (physiologic variation)

Interpretation:

• Osmolar gap > 10: Suggests presence of unmeasured osmoles (toxic alcohols, ketones, mannitol)
• Osmolar gap > 25: Strongly suggests toxic alcohol ingestion
• Osmolar gap > 50: Massive ingestion, high mortality risk

Osmolar gap contribution from toxic alcohols:

• Methanol 10 mg/dL contributes ~3 mOsm/kg
• Ethylene glycol 10 mg/dL contributes ~1.6 mOsm/kg

Limitations:

• False negatives: Late presentation (parent compound metabolized), concurrent ethanol (competes for ADH, slows metabolism but also contributes to gap)
• False positives: Alcoholic ketoacidosis, lactic acidosis, chronic renal failure, hyperlipidemia, hyperproteinemia

Specific Toxic Alcohol Levels

Methanol:

• less than 20 mg/dL: Unlikely to cause toxicity
• 20-40 mg/dL: Mild toxicity possible, especially if acidosis present
• 40-80 mg/dL: Moderate toxicity, visual symptoms likely

• 80 mg/dL: Severe toxicity, high risk of death and permanent blindness [25]

Ethylene glycol:

• less than 20 mg/dL: Unlikely to cause significant toxicity
• 20-50 mg/dL: Mild to moderate toxicity
• 50-100 mg/dL: Severe toxicity, acute kidney injury likely

• 100 mg/dL: Life-threatening toxicity, high mortality risk

Clinical note: Do NOT wait for levels to initiate treatment. Treat empirically based on clinical suspicion, osmolar gap, and anion gap.

Urinalysis

Ethylene glycol:

• Calcium oxalate crystals (present in 30-50% of cases within 4-8 hours of ingestion): [26]
  • "Monohydrate: Envelope-shaped, dumbbell-shaped (spindle)"
  • "Dihydrate: Needle-shaped, prismatic"
  • May require polarized microscopy for optimal visualization
• Hematuria (microscopic or gross)
• Proteinuria (tubular injury)
• Low specific gravity (tubular dysfunction)
• Pyuria

Wood's lamp examination:

• Some antifreeze products contain fluorescein dye (added for leak detection)
• Urine may fluoresce yellow-green under ultraviolet (Wood's lamp)
• Low sensitivity and specificity; absence does not exclude ethylene glycol

Methanol:

• Urinalysis typically unremarkable

Imaging

Computed tomography (CT) brain (non-contrast):

• Methanol: Bilateral putaminal hemorrhage or necrosis (basal ganglia), cerebral edema, optic nerve enhancement (rare)
• Ethylene glycol: Cerebral edema, intracerebral hemorrhage (rare)
• Indicated if altered mental status, seizures, or focal neurological signs

Chest X-ray:

• Pulmonary edema (ethylene glycol-related non-cardiogenic edema)
• Aspiration pneumonia (if altered mental status and vomiting)

Renal ultrasound:

• Ethylene glycol: Echogenic kidneys (calcium oxalate deposition), hydronephrosis (if obstructive crystalluria)

Optical coherence tomography (OCT) of retina:

• Methanol: Retinal nerve fiber layer edema, macular edema
• Emerging tool for prognostication of visual recovery

Electrocardiogram (ECG)

• Ethylene glycol: Prolonged QT interval (hypocalcemia), peaked T waves (hyperkalemia from renal failure), arrhythmias
• Methanol/Ethylene glycol: Sinus tachycardia, non-specific ST-T changes
• Monitor for torsades de pointes (if QTc > 500 ms)

Bedside Tests and Point-of-Care

Formate test (emerging):

• Rapid bedside enzymatic assay detecting formate in blood or urine
• Sensitivity 100%, specificity 94% for methanol poisoning in one study [27]
• Not yet widely available

Arterial blood gas analyzer:

• Provides immediate pH, bicarbonate, anion gap, lactate
• Essential for serial monitoring during treatment

---

Differential Diagnosis

High Anion Gap Metabolic Acidosis (MUDPILES)

Other Causes of Altered Mental Status with Acidosis

• Septic shock: Fever, hypotension, elevated lactate, infectious source
• Seizures (post-ictal): History of epilepsy, witnessed seizure, elevated lactate (transient)
• Carbon monoxide poisoning: Headache, cherry-red skin (rare), elevated carboxyhemoglobin
• Cyanide poisoning: Bitter almond odor, elevated lactate, normal PaO₂ with tissue hypoxia

Causes of Visual Disturbance and Optic Neuropathy

• Methanol poisoning: High anion gap acidosis, osmolar gap, history of ingestion
• Ischemic optic neuropathy: Sudden painless vision loss, vascular risk factors, optic disc pallor
• Optic neuritis: Painful eye movements, central scotoma, multiple sclerosis association
• Quinine toxicity: Tinnitus, cinchonism, fundoscopy shows retinal vasoconstriction
• Ethambutol toxicity: Red-green color blindness, dose-related, gradual onset

---

Management

Initial Resuscitation and Stabilization (ABCDE Approach)

Immediate Antidote Administration

Fomepizole (4-Methylpyrazole) — First-Line Antidote [28]

Mechanism of action:
Competitive inhibitor of alcohol dehydrogenase (ADH) with affinity 500-1000 times greater than ethanol. Prevents metabolism of methanol and ethylene glycol to toxic metabolites (formic acid and glycolic acid, respectively).

Indications for fomepizole:

1. Documented toxic alcohol level (methanol or ethylene glycol) > 20 mg/dL
2. Strong clinical suspicion (history of ingestion + osmolar gap > 10 mOsm/kg)
3. High anion gap metabolic acidosis (AG > 20) with osmolar gap and no alternative cause
4. Visual symptoms suggestive of methanol toxicity
5. Acute kidney injury with calcium oxalate crystals suggestive of ethylene glycol toxicity

Dosing regimen:

Endpoint for fomepizole:
Continue until:

• Methanol/ethylene glycol level less than 20 mg/dL AND
• pH > 7.30 AND
• Patient asymptomatic (no visual symptoms, normal mental status)

Advantages over ethanol:

• No CNS depression
• Predictable pharmacokinetics (no titration required)
• No hypoglycemia risk
• Easier to administer and monitor
• Superior safety profile [29]

Cost consideration:
Fomepizole is expensive (approximately $1000 per vial), but cost-effectiveness analyses favor its use due to reduced ICU stay and complications compared to ethanol.

Adverse effects:

• Nausea, headache, dizziness (mild)
• Phlebitis at IV site
• Rare: Eosinophilia, rash

Cost consideration:
Fomepizole is expensive (approximately $1000 per vial), but cost-effectiveness analyses favor its use due to reduced ICU stay and complications compared to ethanol.

Ethanol — Alternative Antidote (If Fomepizole Unavailable)

Mechanism:
Competitive substrate for alcohol dehydrogenase; preferentially metabolized over methanol/ethylene glycol due to higher ADH affinity.

Indications:
Same as fomepizole (use only if fomepizole unavailable or inaccessible)

Dosing (target serum ethanol concentration 100-150 mg/dL):

Adjustments:

• Chronic drinkers: Increase maintenance by 50% (enzyme induction)
• During hemodialysis: Increase maintenance to 2.5-3.5 mL/kg/hr (ethanol is dialyzable)

Monitoring:
Serum ethanol levels every 2-4 hours (target 100-150 mg/dL)

Disadvantages:

• CNS depression (worsens altered mental status)
• Hypoglycemia (especially in children and malnourished patients)
• Requires frequent monitoring and titration
• IV preparation not widely available
• Fluid overload (large volumes required)

Correction of Metabolic Acidosis

Sodium bicarbonate:

Indications:

• pH less than 7.15 (severe acidosis)
• pH 7.15-7.25 with significant symptoms (altered mental status, hemodynamic instability)

Dosing:

• Bolus: 1-2 mEq/kg (50-100 mEq or 1-2 amps of 8.4% NaHCO₃) IV over 30-60 minutes
• Infusion: 150 mEq (3 amps) in 1 L D5W at 150-250 mL/hr
• Target pH 7.25-7.30 (NOT full correction to 7.40)

Monitoring:

• Repeat VBG every 1-2 hours
• Assess for iatrogenic hypernatremia, volume overload, hypokalemia

Rationale:

• Severe acidosis impairs cardiac contractility, predisposes to arrhythmias
• Bicarbonate provides temporizing measure while definitive treatment (hemodialysis) arranged
• Enhances formate elimination (formate excretion increases at higher pH) [30]

Caution:

• Overly aggressive bicarbonate may cause cerebral alkalosis, hypokalemia, hypocalcemia, volume overload
• Do NOT delay hemodialysis to achieve normal pH with bicarbonate alone

Hemodialysis — Definitive Extracorporeal Treatment

Indications (EXTRIP guidelines): [31]

Type of dialysis:

• Intermittent hemodialysis (IHD): Preferred (most efficient clearance)
• Continuous renal replacement therapy (CRRT): Alternative if IHD unavailable or patient hemodynamically unstable
• Peritoneal dialysis: Ineffective (do NOT use)

Duration:

• Continue until:
  • Methanol/ethylene glycol level less than 20 mg/dL AND
  • pH > 7.30 AND
  • Osmolar gap normalized AND
  • Patient asymptomatic

Typical duration: 8-12 hours (may require multiple sessions)

Effect on clearance:

• Methanol half-life reduced from 14-20 hours (untreated) to 2-3 hours (hemodialysis)
• Ethylene glycol half-life reduced from 3-8 hours (untreated) to 2-3 hours (hemodialysis)

Concurrent fomepizole:

• MUST continue fomepizole during hemodialysis (fomepizole is dialyzable)
• Increase dosing frequency to every 4 hours during dialysis
• Redose after dialysis if last dose > 6 hours prior

Adjunctive Therapies

Folinic Acid / Folic Acid (Methanol Poisoning)

Rationale:
Enhances formate metabolism via the folate-dependent pathway (10-formyltetrahydrofolate synthetase converts formate to CO₂ and H₂O).

Dosing:

• Folinic acid (leucovorin): 1-2 mg/kg (max 50 mg) IV every 4-6 hours
• Folic acid: 50 mg IV every 4-6 hours (alternative if folinic acid unavailable)

Duration:
Continue for 24 hours or until methanol cleared and acidosis resolved.

Evidence:
Limited human data; extrapolated from animal models and case series. Generally considered safe and potentially beneficial. [32]

Thiamine and Pyridoxine (Ethylene Glycol Poisoning)

Rationale:
Cofactors for alternative metabolic pathways that convert glyoxylic acid to non-toxic metabolites (glycine, α-hydroxy-β-ketoadipate) rather than oxalic acid.

Dosing:

• Thiamine (vitamin B₁): 100 mg IV every 6 hours
• Pyridoxine (vitamin B₆): 50 mg IV every 6 hours

Duration:
Continue for 24 hours or until ethylene glycol cleared and acidosis resolved.

Evidence:
Theoretical benefit based on biochemical pathways; limited clinical evidence of efficacy.

Calcium Gluconate (Ethylene Glycol — Hypocalcemia)

Indications:

• Symptomatic hypocalcemia (tetany, seizures, prolonged QT)
• Ionized calcium less than 1.0 mmol/L (less than 4.0 mg/dL)

Dosing:

• 10-20 mL of 10% calcium gluconate IV over 10 minutes (1-2 grams)
• Repeat as needed based on ionized calcium levels
• Alternatively: Continuous infusion 50 mL 10% calcium gluconate in 500 mL D5W at 50-100 mL/hr

Monitoring:

• Ionized calcium every 2-4 hours
• Continuous ECG monitoring (watch for QT prolongation, arrhythmias)

Caution:

• Avoid over-replacement (may worsen calcium oxalate precipitation)
• Target ionized calcium 1.0-1.2 mmol/L (4.0-4.8 mg/dL)

Decontamination (Limited Role)

Gastric lavage / Activated charcoal:

• NOT recommended: Methanol and ethylene glycol are rapidly absorbed (peak levels within 30-90 minutes)
• Charcoal does NOT adsorb alcohols
• Only consider if massive ingestion (less than 1 hour) AND patient presents immediately

Nasogastric aspiration:

• May be attempted if ingestion within 30-60 minutes and large volume suspected
• Protect airway (intubate if altered mental status)

Supportive Care

Monitoring During Treatment

Serial assessments (every 2-4 hours):

• Venous/arterial blood gas: pH, bicarbonate, anion gap
• Serum electrolytes: Sodium, potassium, chloride, calcium (ionized)
• Renal function: Creatinine
• Toxic alcohol levels: Methanol or ethylene glycol (if available)
• Serum osmolality and osmolar gap
• Ethanol level (if ethanol being used as antidote)

Clinical monitoring:

• Vital signs (continuous cardiac monitoring)
• Neurological status (GCS, pupillary response)
• Visual acuity (methanol): Formal ophthalmology assessment
• Urine output (monitor for oliguria/anuria)

Endpoints for treatment cessation:

• Toxic alcohol level less than 20 mg/dL
• pH > 7.30 and stable
• Osmolar gap normalized
• Anion gap normalized (less than 12 mmol/L)
• Patient clinically asymptomatic (normal mental status, no visual symptoms, adequate urine output)

Disposition

ICU admission (all patients with confirmed or suspected toxic alcohol poisoning requiring antidote or hemodialysis)

Psychiatric evaluation: Once medically stable (if intentional self-harm)

Ophthalmology follow-up: All methanol-poisoned patients (assess for delayed optic atrophy)

Nephrology follow-up: Ethylene glycol patients with acute kidney injury (monitor for chronic kidney disease)

---

Complications

Methanol Poisoning

Acute complications:

• Permanent blindness (occurs in 25-33% of survivors with visual symptoms) [33]
• Optic atrophy (irreversible)
• Death (mortality 8-30%)
• Seizures
• Cerebral edema and brainstem herniation
• Aspiration pneumonia

Delayed/chronic complications:

• Permanent visual impairment (partial or complete blindness)
• Parkinsonism (basal ganglia necrosis): Rigidity, bradykinesia, tremor, gait disturbance — may appear weeks to months after recovery
• Cognitive impairment
• Peripheral neuropathy (rare)
• Chronic headaches

Prognostic factors for visual outcomes:

• Initial visual acuity: Better presenting vision associated with better outcomes
• pH at presentation: pH less than 7.0 associated with worse outcomes
• Lactate level: Elevated lactate (> 5 mmol/L) correlates with poor prognosis
• Time to treatment: Delay > 24 hours associated with irreversible damage
• Methanol level: Levels > 80 mg/dL associated with high mortality and morbidity

Ethylene Glycol Poisoning

Acute complications:

• Acute kidney injury requiring dialysis (occurs in 20-50%)
• Death (mortality 1-22% with treatment)
• Hypocalcemia-related: Seizures, arrhythmias (torsades de pointes), tetany
• Cerebral edema and seizures
• Pulmonary edema (non-cardiogenic, ARDS)
• Myocardial dysfunction (calcium oxalate deposition)
• Aspiration pneumonia

Delayed/chronic complications:

• Chronic kidney disease (10-20% require long-term dialysis) [34]
• Residual neurological deficits (rare)
• Cranial nerve palsies (rare)

Prognostic factors for renal outcomes:

• pH at presentation: pH less than 7.0 associated with worse renal outcomes
• Peak creatinine: Creatinine > 5 mg/dL associated with need for long-term dialysis
• Time to treatment: Delay > 24 hours increases risk of irreversible renal damage
• Ethylene glycol level: Levels > 100 mg/dL associated with severe nephrotoxicity

Iatrogenic Complications

From treatment:

• Fomepizole: Generally well tolerated; rare eosinophilia, rash
• Ethanol: CNS depression, hypoglycemia, aspiration
• Sodium bicarbonate: Hypernatremia, volume overload, hypokalemia, cerebral alkalosis
• Hemodialysis: Hypotension, arrhythmias, bleeding (anticoagulation), dialysis disequilibrium syndrome, catheter-related infections

---

Prognosis and Outcomes

Overall Mortality

• Methanol: 8-30% mortality (varies by series, higher in mass outbreaks with delayed care) [35]
• Ethylene glycol: 1-22% mortality with treatment (higher without hemodialysis)
• Untreated toxic alcohol poisoning: Mortality approaches 60-80%

Predictors of Mortality

Poor prognostic indicators:

• pH less than 7.0 at presentation (mortality > 50%)
• Coma at presentation (GCS less than 8)
• Delay to treatment > 24 hours
• Methanol level > 80 mg/dL or ethylene glycol level > 100 mg/dL
• Lactate > 5 mmol/L
• Seizures
• Need for mechanical ventilation

Good prognostic indicators:

• pH > 7.25
• Early presentation (less than 12 hours)
• Prompt antidote administration
• Early hemodialysis

Functional Outcomes

Methanol:

• 25-33% of survivors with visual symptoms develop permanent blindness
• 50-60% of survivors with visual symptoms have partial recovery of vision
• 10-15% develop parkinsonism (delayed onset)
• Most patients who survive without visual symptoms recover fully

Ethylene glycol:

• 10-20% require long-term hemodialysis (end-stage renal disease)
• 30-40% have partial recovery of renal function but with residual chronic kidney disease
• 40-50% recover normal renal function if treated early
• Neurological sequelae rare in survivors

Factors Affecting Long-Term Outcomes

• Time to antidote: Fomepizole within 6 hours associated with excellent outcomes
• Time to hemodialysis: Hemodialysis within 12 hours significantly reduces morbidity
• Severity of acidosis: Duration of pH less than 7.0 correlates with end-organ damage
• Supportive care quality: ICU care, multidisciplinary team (toxicology, nephrology, ophthalmology)

---

Prevention and Public Health

Primary Prevention

Regulatory measures:

• Mandated addition of bittering agents (denatonium benzoate) to antifreeze in many countries (reduces pediatric ingestions)
• Colored dyes in antifreeze (warning signal, though not foolproof)
• Restrictions on methanol sale and labeling requirements
• Public health campaigns during outbreaks

Community education:

• Safe storage of automotive and industrial products (locked cabinets, out of reach of children)
• Avoid consumption of unknown or illicitly produced alcohol
• Warning labels on products containing toxic alcohols

Secondary Prevention (Early Detection)

High-risk populations:

• Homeless shelters and addiction services: Education on risks of surrogate alcohol consumption
• Occupational health: Screening workers in high-exposure industries

Emergency department preparedness:

• High index of suspicion in unexplained high anion gap acidosis
• Rapid access to fomepizole and hemodialysis
• Protocols for empirical treatment before confirmatory levels

Outbreak Response

Mass methanol poisoning events:

• Rapid case identification and triage
• Stockpiling of fomepizole (often limited in resource-constrained settings)
• Ethanol as alternative antidote (more accessible)
• Public health alerts and media campaigns
• Collaboration with toxicology centers and poison control

---

Evidence and Guidelines

Key Guidelines

1. Extracorporeal Treatments in Poisoning (EXTRIP) Workgroup — Methanol Poisoning (2015)
   Systematic review and consensus recommendations on role of hemodialysis in methanol poisoning. Recommends hemodialysis for pH less than 7.15, visual symptoms, renal failure, or methanol level > 50 mg/dL. [36]

2. American Academy of Clinical Toxicology (AACT) Practice Guidelines — Methanol (2002)
   Recommendations on use of fomepizole, ethanol, and hemodialysis. Supports fomepizole as preferred antidote. [37]

3. European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) — Toxic Alcohol Management
   Guideline emphasizing early antidote use and hemodialysis for severe cases.

4. TOXBASE (UK National Poisons Information Service)
   Evidence-based online database for management of poisoning; includes toxic alcohol protocols.

Key Evidence

Fomepizole efficacy:

• Landmark trial by Brent et al. (NEJM 2001) demonstrated fomepizole efficacy in methanol poisoning with favorable safety profile compared to ethanol. [38]
• Meta-analyses show similar efficacy between fomepizole and ethanol for preventing toxic metabolite formation, but fomepizole has superior tolerability.

Hemodialysis benefits:

• Observational studies demonstrate significant mortality reduction with early hemodialysis (relative risk reduction 40-60% compared to antidote alone in severe poisoning).
• Hemodialysis shortens duration of acidosis and accelerates toxic alcohol clearance. [39]

Visual outcomes in methanol:

• Systematic review (Desai et al., JAMA Ophthalmol 2013) identified pH at presentation, lactate level, and time to treatment as key predictors of visual outcomes. [40]
• Long-term cohort study (Zakharov et al., 2015) demonstrated persistent retinal nerve fiber layer (RNFL) thinning on OCT in 50 patients followed for median 24 months, with progressive chronic axonal loss correlating with initial acidosis severity (pH less than 7.0) and delayed treatment. [43]
• Longitudinal OCT study (Nurieva et al., 2018) showed that RNFL thickness decreased by mean 45 μm over 4 years in methanol-poisoned patients, with brain hemorrhages on MRI predicting worse visual outcomes (hazard ratio 4.2, 95% CI 1.8-9.6). [44]

Renal outcomes in ethylene glycol:

• Meta-analysis (Wang et al., Clin Toxicol 2023) found acute kidney injury occurred in 32% of ethylene glycol cases; 15% required long-term dialysis. Early hemodialysis associated with better renal recovery. [41]
• Calcium oxalate crystal formation is mechanistically central to acute kidney injury: both direct tubular obstruction and inflammatory cascade activation contribute to acute tubular necrosis. Animal studies demonstrate that calcium oxalate monohydrate crystals induce greater cytotoxicity than dihydrate forms via oxidative stress and mitochondrial damage. [45]

Areas of Ongoing Research

• Bedside formate testing: Rapid point-of-care enzymatic assays to diagnose methanol poisoning in resource-limited settings
• Optical coherence tomography (OCT): Role in predicting visual recovery in methanol toxicity
• Fomepizole dosing optimization: Pharmacokinetic studies to refine dosing in special populations (obesity, renal failure)
• Alternative ADH inhibitors: Novel agents with improved pharmacologic profiles

---

Patient and Family Information

What is Toxic Alcohol Poisoning?

Toxic alcohol poisoning occurs when someone drinks substances like antifreeze (contains ethylene glycol) or industrial solvents (contain methanol). These are NOT the same as the alcohol found in beer, wine, or spirits (ethanol). The body breaks down toxic alcohols into harmful chemicals that can damage the eyes, kidneys, and brain.

What Causes Toxic Alcohol Poisoning?

• Accidental ingestion: Young children may drink antifreeze because it tastes sweet. Adults with dementia may accidentally consume industrial products.
• Intentional ingestion: People may drink methanol-containing products as substitutes for regular alcohol, or in suicide attempts.
• Contaminated alcohol: Illicit or homemade spirits may be contaminated with methanol, causing mass poisoning events.

What Are the Symptoms?

Early (first 12 hours):

• Feeling drunk (stumbling, slurred speech, confusion)
• Nausea and vomiting
• Stomach pain
• Drowsiness

Later (after 12-24 hours):

• Methanol: Blurred vision or blindness, severe headache, difficulty breathing
• Ethylene glycol: Reduced urination or no urination, severe stomach or back pain, muscle spasms, difficulty breathing

How Is It Diagnosed?

Doctors will:

• Take a detailed history (what was drunk, when, how much)
• Perform blood tests (check for acid buildup, kidney function)
• Measure toxic alcohol levels in the blood (though this may take time)
• Test urine (look for crystals in ethylene glycol poisoning)

How Is It Treated?

Antidote medication (fomepizole or ethanol):
Stops the body from breaking down the toxic alcohol into harmful chemicals. This is given through an IV drip.

Dialysis (blood filtering):
A machine removes the poison from the blood. This is needed in severe cases.

Supportive care:
Medications to correct the acid buildup in the blood, fluids through an IV, and monitoring in an intensive care unit.

What Is the Outlook?

With early treatment:

• Most people recover fully if treated within the first few hours.
• The sooner treatment starts, the better the outcome.

With delayed treatment:

• Methanol: Risk of permanent blindness (25-30% of survivors)
• Ethylene glycol: Risk of permanent kidney damage requiring lifelong dialysis (10-20% of survivors)
• Death (20-40% without treatment)

How Can It Be Prevented?

• Store antifreeze and solvents safely: Keep in locked cabinets, away from children.
• Never drink unknown liquids: Especially homemade or unlabeled alcohol.
• Supervise children: Ensure they cannot access automotive or industrial products.
• Educate vulnerable individuals: Explain the dangers to those with alcohol use disorder or dementia.

When to Seek Emergency Help

Call emergency services (911/999) immediately if someone:

• Has drunk antifreeze, windscreen washer fluid, or industrial solvents
• Is confused, drowsy, or unconscious after drinking unknown alcohol
• Has blurred vision or vision loss after drinking
• Is breathing rapidly or has difficulty breathing
• Has reduced urination or no urination

Do NOT wait for symptoms to worsen. Early treatment saves lives and prevents disability.

Resources

• Poison Control Centers: Call local poison control for immediate guidance
  • "US: 1-800-222-1222"
  • "UK: 111 (NHS 111)"
• TOXBASE (UK): https://www.toxbase.org (for healthcare professionals)
• NHS Poisoning Information: https://www.nhs.uk/conditions/poisoning/

---

Clinical Vignettes and Case Studies

Case 1: Classic Methanol Poisoning with Visual Symptoms

Presentation:
A 45-year-old man with alcohol use disorder presents to the emergency department 18 hours after drinking a bottle of windscreen washer fluid. He initially felt intoxicated but now complains of severe headache, blurred vision ("like looking through snow"), and rapid breathing. On examination, he is tachypneic (respiratory rate 32/min), confused (GCS 13), and has bilaterally dilated pupils with sluggish light reflexes. Visual acuity is counting fingers at 1 meter bilaterally.

Investigations:

• ABG: pH 7.02, PaCO₂ 18 mmHg, HCO₃⁻ 5 mmol/L, lactate 4.2 mmol/L
• Electrolytes: Na 142, K 3.8, Cl 108, HCO₃⁻ 5 mmol/L → Anion gap = 29 mmol/L
• Serum osmolality (measured): 328 mOsm/kg
• Calculated osmolality: 2(142) + 5.5/18 + 7/2.8 = 289 mOsm/kg → Osmolar gap = 39 mOsm/kg
• Methanol level (returned 6 hours later): 85 mg/dL

Immediate management:

1. Fomepizole 15 mg/kg IV loading dose (within 30 minutes of arrival)
2. Sodium bicarbonate: 3 amps (150 mEq) in 1 L D5W at 200 mL/hr
3. Folinic acid 50 mg IV every 4 hours
4. Urgent nephrology consult → hemodialysis initiated within 2 hours
5. Ophthalmology consult → fundoscopy shows bilateral optic disc hyperemia

Outcome:
After 10 hours of hemodialysis, pH improved to 7.28, methanol level less than 10 mg/dL. Patient recovered consciousness but had persistent bilateral visual impairment (visual acuity 6/60 bilaterally). At 3-month follow-up, optic atrophy present with permanent vision loss.

Teaching points:

• Visual symptoms = absolute indication for hemodialysis
• Osmolar gap can coexist with anion gap during metabolic transition
• Severe acidosis (pH less than 7.0) associated with poor visual prognosis
• Optic disc hyperemia is an early specific sign for methanol toxicity

---

Case 2: Ethylene Glycol Poisoning with Acute Kidney Injury

Presentation:
A 32-year-old homeless man is found confused and brought to the ED by paramedics. Witnesses report he drank antifreeze 14 hours ago. He is drowsy (GCS 12), tachypneic (RR 28/min), and complains of flank pain and inability to urinate for 8 hours.

Investigations:

• VBG: pH 7.12, HCO₃⁻ 8 mmol/L
• Electrolytes: Na 138, K 5.2, Cl 105, HCO₃⁻ 8 mmol/L → Anion gap = 25 mmol/L
• Ionized calcium: 0.85 mmol/L (low)
• Creatinine: 4.8 mg/dL (baseline unknown but likely normal)
• Serum osmolality (measured): 310 mOsm/kg
• Calculated osmolality: 286 mOsm/kg → Osmolar gap = 24 mOsm/kg
• Urinalysis: Envelope-shaped calcium oxalate monohydrate crystals, hematuria
• ECG: QTc 485 ms (prolonged)
• Ethylene glycol level (returned 8 hours later): 92 mg/dL

Immediate management:

1. Fomepizole 15 mg/kg IV loading dose
2. Calcium gluconate 2 grams (20 mL 10% solution) IV over 10 minutes for hypocalcemia
3. Sodium bicarbonate 100 mEq IV bolus
4. Thiamine 100 mg IV and pyridoxine 50 mg IV every 6 hours
5. Urgent hemodialysis (AKI with oliguria, severe acidosis)

Outcome:
Hemodialysis for 12 hours. pH normalized to 7.34, ethylene glycol level less than 15 mg/dL. Creatinine peaked at 6.2 mg/dL on day 3, then gradually improved. Patient required temporary hemodialysis for 2 weeks, then renal function partially recovered (discharge creatinine 2.1 mg/dL). At 6-month follow-up, creatinine stabilized at 1.8 mg/dL (stage 2 CKD).

Teaching points:

• Calcium oxalate crystals are pathognomonic but only present in 50% of cases
• Hypocalcemia in ethylene glycol → QT prolongation → arrhythmia risk
• AKI + acidosis = absolute hemodialysis indication
• Partial renal recovery common; 10-20% need long-term dialysis

---

Case 3: Delayed Presentation — Normal Osmolar Gap

Presentation:
A 28-year-old woman presents 36 hours after intentional ingestion of methanol (suicide attempt). She initially vomited and felt drunk but delayed seeking care. Now she has severe headache, dyspnea, and "can't see properly." On examination: GCS 14, RR 30/min, BP 95/60 mmHg, visual acuity light perception only bilaterally.

Investigations:

• ABG: pH 6.92, PaCO₂ 12 mmHg, HCO₃⁻ 3 mmol/L, lactate 6.8 mmol/L
• Anion gap: 38 mmol/L
• Serum osmolality (measured): 295 mOsm/kg
• Calculated osmolality: 292 mOsm/kg → Osmolar gap = 3 mOsm/kg (normal!)
• Methanol level: 12 mg/dL (low, but formate already formed)

Key teaching point:
Normal osmolar gap does NOT exclude toxic alcohol poisoning in delayed presentations. By 36 hours, methanol (parent compound) has been metabolized to formic acid (metabolite), so osmolar gap normalizes while anion gap is markedly elevated. Clinical suspicion and history are paramount.

Management:

• Immediate fomepizole 15 mg/kg IV
• Aggressive bicarbonate infusion (pH critically low)
• Emergent hemodialysis (despite low methanol level, severe acidosis and visual symptoms mandate dialysis to remove formate)
• Folinic acid 50 mg IV every 4 hours

Outcome:
Despite aggressive treatment, patient had profound lactic acidosis and severe formate accumulation. Required prolonged hemodialysis (16 hours). pH eventually improved to 7.25. However, visual loss was permanent (bilateral blindness).

Teaching points:

• Delayed presentation = worse prognosis (irreversible formate-mediated damage)
• Osmolar gap may be normal if parent compound already metabolized
• Formate (not methanol) causes toxicity; even low methanol levels can have severe formate accumulation
• Hemodialysis indicated for severe acidosis and visual symptoms regardless of methanol level

---

Case 4: Mass Poisoning Outbreak — Resource-Limited Setting

Scenario:
During a religious festival in a rural area, 47 individuals consumed illicitly produced alcohol contaminated with methanol. Eighteen presented to a local district hospital over 24 hours with vomiting, confusion, visual disturbances, and respiratory distress.

Challenges:

• Fomepizole unavailable (cost-prohibitive, no stock)
• Limited hemodialysis capacity (only 2 machines)
• No toxic alcohol levels available

Triage and management strategy:

Tier 1 (highest priority for hemodialysis):

• Visual symptoms + pH less than 7.1 (6 patients)
• Management: Ethanol infusion (10% IV), hemodialysis in rotation

Tier 2 (moderate priority):

• pH 7.1-7.25 without visual symptoms (8 patients)
• Management: Ethanol infusion, folic acid 50 mg IV q6h, bicarbonate, serial monitoring

Tier 3 (observation):

• Mild symptoms, pH > 7.25, no visual complaints (4 patients)
• Management: Ethanol infusion, supportive care, watch for deterioration

Ethanol protocol (no fomepizole available):

• Loading: 10% ethanol in D5W, 8 mL/kg IV over 1 hour
• Maintenance: 1.5 mL/kg/hr IV continuous infusion
• Target serum ethanol: 100-150 mg/dL (checked every 4 hours)

Outcome:

• 4 deaths (3 with severe acidosis pH less than 6.9 and delayed presentation, 1 with aspiration pneumonia)
• 6 permanent blindness
• 8 recovered with partial visual impairment

Teaching points:

• Ethanol is effective alternative when fomepizole unavailable (common in resource-limited settings)
• Triage based on severity (visual symptoms, pH) when hemodialysis limited
• Folic acid used instead of folinic acid (more available, cheaper)
• Mass poisoning outbreaks highlight need for public health interventions (regulation of illicit alcohol)

---

Detailed Management Algorithms

Algorithm 1: Initial Assessment and Diagnosis

Patient with suspected toxic alcohol ingestion
                    ↓
STEP 1: Clinical assessment
- History: Ingestion of antifreeze, solvent, illicit alcohol?
- Symptoms: Inebriation, visual disturbance, dyspnea, oliguria?
- Examination: GCS, visual acuity, Kussmaul breathing, pupils
                    ↓
STEP 2: Immediate investigations
- VBG/ABG (pH, HCO₃⁻, calculate anion gap)
- Electrolytes (calculate anion gap)
- Serum osmolality (MEASURED, not calculated)
- Calculate osmolar gap
- Creatinine, ionized calcium
- Urinalysis (calcium oxalate crystals?)
- Toxic alcohol levels (methanol, ethylene glycol, ethanol)
- ECG
                    ↓
STEP 3: Diagnostic criteria (any ONE of the following)
┌─────────────────────────────────────────────────────┐
│ 1. Documented methanol or EG level > 20 mg/dL       │
│ 2. History of ingestion + osmolar gap > 10 mOsm/kg  │
│ 3. Unexplained HAGMA (AG > 20) + osmolar gap > 10    │
│ 4. Visual symptoms + HAGMA                          │
│ 5. AKI + calcium oxalate crystals + HAGMA          │
└─────────────────────────────────────────────────────┘
                    ↓
            Diagnosis confirmed
                    ↓
        Proceed to ALGORITHM 2: Treatment

---

Algorithm 2: Treatment Decision Pathway

Toxic alcohol poisoning diagnosed
                    ↓
IMMEDIATE (within 30 minutes):
- Fomepizole 15 mg/kg IV loading dose
- Supportive care (airway, breathing, circulation)
- Bicarbonate if pH less than 7.15
- Calcium gluconate if ionized Ca less than 1.0 mmol/L (EG)
                    ↓
ASSESS SEVERITY (determine need for hemodialysis)
                    ↓
┌─────────────────────────────────────────────────────┐
│ ABSOLUTE INDICATIONS FOR HEMODIALYSIS (any ONE):   │
│ 1. pH less than 7.25 (severe metabolic acidosis)             │
│ 2. Visual symptoms (methanol)                        │
│ 3. Acute kidney injury (EG): Cr > 3 mg/dL, oliguria │
│ 4. Seizures, coma, refractory symptoms              │
│ 5. Toxic alcohol level > 50 mg/dL                    │
│ 6. Osmolar gap > 25 mOsm/kg (massive ingestion)     │
│ 7. Persistent acidosis despite bicarbonate          │
└─────────────────────────────────────────────────────┘
                    ↓
         YES (any indication)         NO
                ↓                      ↓
        HEMODIALYSIS         Fomepizole alone + monitoring
                ↓                      ↓
    Continue fomepizole q4h    Fomepizole 10 mg/kg q12h
    during hemodialysis        Monitor: pH, AG, levels q4h
                ↓                      ↓
    Duration: Until all met:    Watch for deterioration
    - Level less than 20 mg/dL                 ↓
    - pH > 7.30                If worsens → Hemodialysis
    - Osmolar gap normal
    - Asymptomatic
                ↓
        Transition to monitoring phase

---

Algorithm 3: Fomepizole Dosing During Hemodialysis

Patient on fomepizole + hemodialysis initiated
                    ↓
ADJUST FOMEPIZOLE DOSING (fomepizole is dialyzable)
                    ↓
┌─────────────────────────────────────────────────────┐
│ DURING HEMODIALYSIS:                                │
│ - Give fomepizole every 4 hours (instead of q12h)   │
│ - Dose: 10 mg/kg IV every 4 hours                   │
│                                                      │
│ AT START OF HEMODIALYSIS:                           │
│ - If last dose was > 6 hours ago: Give 15 mg/kg      │
│ - If last dose was less than 6 hours ago: Continue schedule  │
│                                                      │
│ AFTER HEMODIALYSIS ENDS:                            │
│ - If time since last dose ≥6 hours: Give dose       │
│ - Then resume q12h schedule                          │
└─────────────────────────────────────────────────────┘
                    ↓
Continue until endpoints met (see Algorithm 2)

---

Algorithm 4: Bicarbonate Therapy

Patient with toxic alcohol poisoning + metabolic acidosis
                    ↓
CHECK pH
                    ↓
┌──────────┬──────────┬──────────┐
│ pH ≥7.25 │ pH 7.15- │ pH less than 7.15 │
│          │   7.24   │          │
└────┬─────┴────┬─────┴────┬─────┘
     ↓          ↓          ↓
  Monitor   Consider  GIVE BICARBONATE
            bicarb    Immediately
                ↓          ↓
        If symptoms   Loading dose:
        (confusion,   100-150 mEq IV
        hypotension)  over 30-60 min
                ↓          ↓
           Give bicarb  Then infusion:
                       150 mEq in 1L D5W
                       at 150-250 mL/hr
                            ↓
                    TARGET pH 7.25-7.30
                    (NOT full correction)
                            ↓
                    Recheck VBG q1-2h
                            ↓
               SIMULTANEOUSLY arrange hemodialysis
               (bicarbonate is temporizing, NOT definitive)

---

Examination Pearls and OSCE Scenarios

OSCE Station 1: Fundoscopy in Methanol Toxicity

Scenario:
You are the medical registrar on call. A 38-year-old man with suspected methanol poisoning has been admitted. The consultant asks you to perform fundoscopy and report your findings.

Expected findings:

Early (24-48 hours):

• Optic disc hyperemia: Reddened, hyperemic optic disc ("cherry red disc")
• Optic disc edema (blurred disc margins)
• Retinal edema (cloudy, whitish appearance around vessels)
• Retinal venous engorgement

Late (> 48 hours, survivors):

• Optic atrophy: Pale optic disc (loss of pink color)
• Attenuated retinal vessels
• Macular changes (edema or scarring)

Key differentiating features:

Viva questions you should be able to answer:

1. What is the significance of optic disc hyperemia in this context?
   • Early specific sign of methanol toxicity indicating formic acid damage to optic nerve
2. Why does methanol cause optic neuropathy?
   • Formic acid inhibits cytochrome oxidase in retinal ganglion cells, causing mitochondrial dysfunction and cell death
3. Is optic disc hyperemia reversible?
   • Potentially, if treated early with hemodialysis to remove formate; however, optic atrophy (late finding) is irreversible

---

OSCE Station 2: Urinalysis Interpretation — Calcium Oxalate Crystals

Scenario:
A confused patient presents with high anion gap metabolic acidosis. You are shown a urine microscopy slide.

Findings:
Envelope-shaped crystals and needle-shaped crystals visible under light microscopy.

Expected response:

Identification:

• "This urinalysis shows calcium oxalate crystals."
• "The envelope-shaped crystals are calcium oxalate monohydrate."
• "The needle-shaped crystals are calcium oxalate dihydrate."

Clinical significance:

• "These crystals are pathognomonic for ethylene glycol poisoning."
• "They indicate metabolism of ethylene glycol to oxalic acid, which binds calcium to form calcium oxalate."
• "Crystal deposition in renal tubules causes acute tubular necrosis and acute kidney injury."

Limitations:

• "These crystals are only present in 30-50% of ethylene glycol poisoning cases."
• "Absence of crystals does NOT exclude ethylene glycol toxicity."
• "Diagnosis should not rely solely on urinalysis; clinical suspicion, osmolar gap, and anion gap are critical."

Immediate actions:

1. Administer fomepizole immediately (do NOT wait for ethylene glycol level)
2. Check ionized calcium (likely low due to calcium chelation by oxalate)
3. Give calcium gluconate if symptomatic hypocalcemia
4. Arrange urgent hemodialysis
5. Give thiamine and pyridoxine as cofactors

Viva questions:

1. What other crystals can be seen in urine, and how do you differentiate them?
   • Uric acid crystals: rhomboid or rosette-shaped, yellow-brown; struvite (triple phosphate): "coffin lid" shaped; cystine: hexagonal
2. Why does calcium drop in ethylene glycol poisoning?
   • Oxalic acid chelates calcium to form calcium oxalate precipitate
3. What are the consequences of hypocalcemia?
   • QT prolongation, torsades de pointes, tetany, seizures, carpopedal spasm (Trousseau sign), facial twitching (Chvostek sign)

---

OSCE Station 3: Calculating Osmolar Gap and Anion Gap

Scenario:
A 42-year-old man presents with altered mental status. You are given the following blood results and asked to calculate osmolar gap and anion gap, and interpret the findings.

Blood results:

• Na: 140 mmol/L
• K: 4.2 mmol/L
• Cl: 102 mmol/L
• HCO₃⁻: 10 mmol/L
• Glucose: 90 mg/dL (5 mmol/L)
• BUN: 14 mg/dL (5 mmol/L urea)
• Measured serum osmolality: 340 mOsm/kg
• Ethanol level: 0 mg/dL

Expected calculations:

1. Anion gap:

AG = Na - (Cl + HCO₃⁻)
AG = 140 - (102 + 10)
AG = 28 mmol/L (markedly elevated; normal 8-12)

2. Calculated osmolality:

Calculated osmolality = 2(Na) + Glucose/18 + BUN/2.8
= 2(140) + 90/18 + 14/2.8
= 280 + 5 + 5
= 290 mOsm/kg

3. Osmolar gap:

Osmolar gap = Measured osmolality - Calculated osmolality
= 340 - 290
= 50 mOsm/kg (markedly elevated; normal -10 to +10)

Interpretation:

"This patient has:

1. High anion gap metabolic acidosis (AG 28 mmol/L) indicating accumulation of unmeasured anions
2. Elevated osmolar gap (50 mOsm/kg) indicating presence of unmeasured osmoles

Together, these findings are highly suggestive of toxic alcohol poisoning (methanol or ethylene glycol). The very high osmolar gap (50 mOsm/kg) suggests massive ingestion and early presentation (parent compound still present).

Given the combination of HAGMA and large osmolar gap, I would:

1. Immediately administer fomepizole 15 mg/kg IV
2. Send toxic alcohol levels (methanol, ethylene glycol)
3. Check for clinical clues: visual symptoms (methanol) or calcium oxalate crystals in urine (ethylene glycol)
4. Arrange urgent hemodialysis (osmolar gap > 25 is an indication)
5. Give supportive care and bicarbonate if pH less than 7.15"

Viva questions:

1. What else can cause an elevated osmolar gap?
   • MEDICS mnemonic: Methanol, Ethanol, Diethylene/Ethylene glycol, Isopropanol, Chronic renal failure (uremia), Sorbitol/mannitol, Ketones (DKA, AKA)
2. Why might osmolar gap be normal in toxic alcohol poisoning?
   • Delayed presentation: Parent compound (methanol/EG) already metabolized to toxic acids; osmolar gap normalizes but anion gap rises
3. What is the delta-delta ratio and why is it useful?
   • Δ-Δ = (AG-12)/(24-HCO₃⁻); helps identify mixed acid-base disorders; ratio 1-2 = pure HAGMA; less than 1 = concurrent NAGMA; > 2 = concurrent metabolic alkalosis

---

OSCE Station 4: Communication — Explaining Toxic Alcohol Poisoning to a Patient's Family

Scenario:
You are the ICU registrar. A 50-year-old man has been admitted with methanol poisoning after drinking contaminated spirits. His wife asks you to explain what is happening.

Expected communication structure:

1. Introduction and establish understanding:

• "I'm Dr. [Name], the intensive care doctor looking after your husband."
• "I understand this is a very worrying time. Can I check what you've been told so far?"

2. Explain the condition in lay terms:

• "Your husband has drunk a substance called methanol, which is a type of toxic alcohol found in some solvents and contaminated spirits."
• "Methanol is very different from the alcohol in beer or wine. When the body breaks it down, it produces harmful chemicals that damage the eyes and other organs."
• "The most serious risk is permanent blindness and severe acid buildup in the blood, which can be life-threatening."

3. Explain the treatment:

• "We're giving him three main treatments:
  1. An antidote medicine called fomepizole that stops his body from breaking down the methanol into the harmful chemicals.
  2. Dialysis, which is like filtering the blood through a machine to remove the poison.
  3. Supportive treatment to correct the acid buildup and support his breathing and blood pressure."

4. Explain the prognosis honestly:

• "The next 24-48 hours are critical. Because he came in with severe symptoms and his blood was very acidic, there is a risk of:
  • Permanent damage to his vision (he may lose some or all of his sight)
  • Temporary kidney damage
  • In the worst cases, this can be fatal, though we are doing everything we can."
• "The good news is that he's now receiving the correct treatment, and we'll monitor him very closely."

5. Address questions and concerns:

• Allow time for questions
• "Do you have any questions about what I've explained?"

6. Arrange follow-up:

• "I'll update you every few hours as we monitor his progress."
• "If his condition changes, we'll inform you immediately."

Key communication skills:

• Empathy and sensitivity (life-threatening condition)
• Avoid jargon (use "toxic alcohol" not "methanol," "antidote" not "fomepizole")
• Honest about prognosis without removing hope
• Structured explanation (condition → treatment → prognosis)

---

Pharmacology Deep Dive: Fomepizole

Mechanism of Action (Molecular Level)

Fomepizole (4-methylpyrazole, 4-MP) is a competitive inhibitor of alcohol dehydrogenase (ADH), the rate-limiting enzyme responsible for metabolizing methanol and ethylene glycol to their toxic metabolites.

Enzyme kinetics:

• Binding affinity: Fomepizole has 500-1000 times higher affinity for ADH than ethanol
• Ki (inhibition constant): 0.01-0.1 μM (compared to ethanol Ki ~1 mM)
• Effect: Near-complete inhibition of ADH at therapeutic concentrations (10-20 mg/L)

Result of ADH inhibition:

• Methanol and ethylene glycol remain unmetabolized (parent compounds are relatively non-toxic)
• Parent compounds are excreted unchanged via kidneys (50-80%) and lungs (20-30%)
• Half-life of methanol extends from 14-20 hours to 30-54 hours
• Half-life of ethylene glycol extends from 3-8 hours to 17-20 hours
• Allows time for renal excretion or hemodialysis removal without formation of toxic metabolites (formic acid, glycolic acid)

Pharmacokinetics

Dosing Regimen (Detailed)

Loading dose:
15 mg/kg IV over 30 minutes (maximum concentration 100 mg/mL in saline or D5W)

Maintenance dosing:

Endpoint for discontinuation:
All of the following must be met:

1. Toxic alcohol level less than 20 mg/dL
2. pH > 7.30
3. Patient asymptomatic (normal mental status, no visual symptoms)
4. Osmolar gap normalized

Typical duration: 24-72 hours (longer if delayed presentation or inadequate hemodialysis)

Adverse Effects

Common (> 1%):

• Headache (10-15%)
• Nausea (5-10%)
• Dizziness, vertigo (5%)
• Phlebitis at IV site (5%)

Uncommon (less than 1%):

• Rash
• Eosinophilia (transient)
• Elevated liver transaminases (usually mild)

Rare:

• Seizures (case reports, causality uncertain)
• Anaphylaxis (very rare)

Advantages over ethanol:

• No CNS depression
• Predictable pharmacokinetics (no need for frequent level monitoring)
• No hypoglycemia risk
• No risk of worsening intoxication
• Easier nursing administration
• Superior tolerability

Disadvantages:

• High cost (approximately $1,000-3,500 per vial; treatment course $5,000-15,000)
• May not be available in resource-limited settings
• Requires IV access

Drug Interactions

• CYP450 inducers (phenytoin, carbamazepine): May increase fomepizole clearance (unlikely to be clinically significant)
• Alcohol: Fomepizole inhibits ethanol metabolism; may prolong ethanol intoxication if co-ingested (not clinically problematic)

Special Populations

Renal impairment:

• No dose adjustment needed (fomepizole is hepatically metabolized)
• However, if patient on hemodialysis for renal failure, adjust frequency as per hemodialysis protocol

Hepatic impairment:

• Use with caution (hepatic metabolism)
• Monitor for prolonged half-life
• No specific dose adjustment guidelines

Pregnancy:

• Category C (animal studies show adverse effects, human data limited)
• Use if benefit outweighs risk (toxic alcohol poisoning is life-threatening)
• Case reports of successful use in pregnancy without fetal harm

Pediatrics:

• Safe and effective in children
• Dose: 15 mg/kg loading, 10 mg/kg q12h maintenance (same as adults on per-kg basis)

---

Comparative Toxicology: Other Toxic Alcohols

Isopropanol (Isopropyl Alcohol)

Sources:
Rubbing alcohol (70-90% isopropanol), hand sanitizer, disinfectants, solvents

Metabolism:
Isopropanol → Acetone (via alcohol dehydrogenase)

Clinical features:

• Inebriation (more pronounced than ethanol, "drunk without the smell of alcohol")
• Gastric irritation (nausea, vomiting, abdominal pain, hemorrhagic gastritis)
• NO metabolic acidosis (acetone is not an acid)
• Elevated osmolar gap (both isopropanol and acetone contribute)
• Ketones in blood and urine (acetone), but normal glucose
• "Fruity" breath odor (acetone)

Key differentiating features:

• Osmolar gap WITHOUT anion gap acidosis (major difference from methanol/ethylene glycol)
• Ketonemia/ketonuria without hyperglycemia (differentiates from diabetic ketoacidosis)

Treatment:

• Supportive care (usually self-limiting)
• No fomepizole or hemodialysis needed (acetone is not toxic)
• Hemodialysis only if severe refractory hypotension or coma (rare)

---

Propylene Glycol

Sources:
Pharmaceutical solvent (IV lorazepam, diazepam, phenobarbital, esmolol), antifreeze (non-toxic alternative to ethylene glycol), cosmetics

Metabolism:
Propylene glycol → Lactic acid + Pyruvic acid (via alcohol dehydrogenase and aldehyde dehydrogenase)

Clinical features:

• Iatrogenic toxicity (excessive IV drug administration, especially lorazepam in ICU)
• Lactic acidosis (elevated lactate, high anion gap)
• Elevated osmolar gap
• Hypotension, arrhythmias (direct myocardial depression)
• Acute kidney injury (tubular toxicity)
• CNS depression (seizures, coma)

Diagnosis:

• High clinical suspicion in ICU patients on continuous IV lorazepam or diazepam
• Elevated osmolar gap + lactic acidosis + recent high-dose sedative infusions

Treatment:

• Discontinue offending agent (switch from lorazepam to propofol or midazolam)
• Supportive care
• Hemodialysis if severe (propylene glycol is dialyzable)
• Fomepizole NOT routinely used (limited evidence)

---

Diethylene Glycol

Sources:
Industrial solvent, antifreeze, contamination of pharmaceutical products (tragic mass poisonings in Panama, Haiti, Nigeria)

Metabolism:
Diethylene glycol → 2-Hydroxyethoxyacetic acid (via alcohol dehydrogenase)

Clinical features:

• Similar to ethylene glycol (metabolic acidosis, acute kidney injury)
• Neurological toxicity (peripheral neuropathy, cranial nerve palsies, encephalopathy)
• Hepatotoxicity (elevated transaminases)

Treatment:

• Fomepizole (blocks metabolism)
• Hemodialysis (severe cases)
• Prognosis often poor (delayed presentation in mass poisonings)

---

Summary Table: Toxic Alcohols Comparison

---

Advanced Topics for Viva Preparation

Question 1: Why does methanol specifically damage the optic nerve?

Expected answer:

"Methanol's toxic metabolite, formic acid, causes optic neuropathy through several mechanisms:

1. Mitochondrial toxicity: Formic acid inhibits cytochrome c oxidase (complex IV of the electron transport chain), impairing ATP production. The retina and optic nerve have extremely high metabolic demands and are therefore uniquely vulnerable to this histotoxic hypoxia.

2. Selective accumulation: Formate accumulates preferentially in the vitreous humor and retina due to poor clearance from these compartments.

3. Retinal ganglion cell death: Formic acid causes apoptosis of retinal ganglion cells, whose axons form the optic nerve. Loss of these cells leads to optic atrophy.

4. Retrolaminar demyelination: Formate damages the optic nerve posterior to the lamina cribrosa, causing axonal injury and demyelination.

5. Folate depletion: Formate metabolism requires folate-dependent pathways. Depletion of folate impairs formate clearance, worsening accumulation in ocular tissues.

The result is permanent vision loss if treatment is delayed, as retinal ganglion cells cannot regenerate."

---

Question 2: Explain the role of hemodialysis in toxic alcohol poisoning. Why is it superior to fomepizole alone in severe cases?

Expected answer:

"Hemodialysis is the definitive treatment for severe toxic alcohol poisoning and offers advantages beyond fomepizole alone:

Mechanisms of benefit:

1. Removal of parent compound: Hemodialysis efficiently clears methanol and ethylene glycol (small molecules, low molecular weight, not protein-bound). Clearance rate 150-200 mL/min, reducing half-life from 14-20 hours to 2-3 hours.

2. Removal of toxic metabolites: Critically, hemodialysis also removes formic acid (methanol) and glycolic acid (ethylene glycol), which cause end-organ damage. Fomepizole only prevents new metabolite formation but does NOT remove existing metabolites.

3. Correction of acidosis: Bicarbonate dialysate buffers severe metabolic acidosis, rapidly improving pH. This is superior to IV bicarbonate alone, which can cause volume overload and hypernatremia.

4. Electrolyte correction: Corrects hyperkalemia (from AKI), replenishes bicarbonate, manages sodium.

5. Faster recovery: Shortens ICU stay and duration of toxicity by accelerating toxin elimination.

Why superior to fomepizole alone in severe cases:

• Fomepizole only prevents further metabolism (stops the clock) but doesn't remove existing toxins or metabolites
• In severe poisoning with established acidosis and metabolite accumulation, waiting for renal excretion takes too long (irreversible damage occurs)
• Hemodialysis is both preventive (removes parent compound) and therapeutic (removes metabolites, corrects acidosis)

EXTRIP guidelines recommend hemodialysis for pH less than 7.25, end-organ damage (visual symptoms, AKI), or levels > 50 mg/dL."

---

Question 3: A patient with suspected methanol poisoning has a normal osmolar gap. Does this exclude the diagnosis?

Expected answer:

"No, a normal osmolar gap does NOT exclude toxic alcohol poisoning. This is a common pitfall.

Reasons for normal osmolar gap despite toxic alcohol poisoning:

1. Delayed presentation: If the patient presents > 12-24 hours after ingestion, the parent compound (methanol or ethylene glycol) may already be metabolized to toxic acids. The osmolar gap normalizes as the parent compound is cleared, but the anion gap rises due to metabolite accumulation.

2. Concurrent ethanol ingestion: Ethanol competitively inhibits ADH, slowing methanol/ethylene glycol metabolism. This prolongs the half-life but also means ethanol contributes to the osmolar gap, potentially masking the toxic alcohol contribution.

3. Low sensitivity: Osmolar gap has a sensitivity of only 73-87% for toxic alcohols. Physiologic variation in osmolar gap (-10 to +10 mOsm/kg) can obscure small elevations.

4. Laboratory error: Measured osmolality may be affected by analytical method (freezing point depression vs. vapor pressure).

Clinical approach:

• Rely on clinical suspicion (history, unexplained HAGMA) rather than osmolar gap alone
• Anion gap is more reliable in late presentations (toxic metabolites present)
• Empirical treatment: If strong suspicion, administer fomepizole even with normal osmolar gap
• Serial measurements: Osmolar gap may evolve over time; repeat measurements can be informative

Key teaching point: Osmolar gap is useful when positive (supports diagnosis) but does NOT exclude poisoning when negative/normal."

---

Question 4: How would you manage a pregnant woman with ethylene glycol poisoning?

Expected answer:

"Toxic alcohol poisoning in pregnancy is rare but life-threatening for both mother and fetus. Management follows the same principles as non-pregnant patients, with considerations for fetal safety.

Immediate management (same as non-pregnant patients):

1. Fomepizole: Administer immediately (15 mg/kg IV loading dose). Although pregnancy category C, the risk of untreated toxic alcohol poisoning far outweighs theoretical fetal risk. Case reports show successful use in pregnancy without adverse fetal outcomes.

2. Hemodialysis: Indicated for same criteria (pH less than 7.25, AKI, severe symptoms). Hemodialysis is safe in pregnancy and essential to prevent maternal and fetal death.

3. Supportive care: Bicarbonate for acidosis, calcium gluconate for hypocalcemia, thiamine and pyridoxine as cofactors.

Pregnancy-specific considerations:

1. Fetal monitoring: Continuous fetal heart rate monitoring (if viable gestational age, typically > 24 weeks). Severe maternal acidosis causes fetal distress.

2. Obstetric consultation: Involve obstetrics early for fetal assessment and delivery planning if needed.

3. Fetal toxicity: Methanol and ethylene glycol cross the placenta. Fetal alcohol dehydrogenase activity is lower, so fetal metabolism is slower, but fetal acidosis mirrors maternal acidosis.

4. Teratogenicity: Fomepizole has no known teratogenic effects. Ethanol (alternative antidote) is teratogenic (fetal alcohol syndrome) but may be necessary if fomepizole unavailable.

5. Delivery timing: Do NOT rush to delivery unless fetal distress or maternal instability. Correct maternal acidosis first; fetal outcomes improve with maternal stabilization.

Prognosis:

• Maternal survival and fetal survival both depend on rapid treatment
• Successful pregnancies reported with fomepizole + hemodialysis
• Fetal demise risk high if maternal pH less than 7.0 or delayed treatment

Key principle: Treat the mother aggressively; fetal outcomes improve when maternal condition stabilizes."

---

Question 5: Describe the use of folinic acid and folic acid in methanol poisoning. What is the evidence?

Expected answer:

"Folinic acid (leucovorin) and folic acid are adjunctive therapies in methanol poisoning, aimed at enhancing formate metabolism.

Rationale:

Formic acid (methanol's toxic metabolite) is eliminated via a folate-dependent pathway:

• Formate + Tetrahydrofolate → 10-Formyltetrahydrofolate → CO₂ + H₂O
• Enzyme: 10-formyltetrahydrofolate synthetase (folate-dependent)

Methanol poisoning may deplete folate stores, impairing formate clearance. Supplementation theoretically enhances formate metabolism and accelerates elimination.

Folinic acid (leucovorin) vs. Folic acid:

Evidence:

• Animal studies: Demonstrate enhanced formate clearance and reduced toxicity with folate supplementation
• Human evidence: Limited to case reports and case series; no randomized controlled trials
• Observational data: Suggests potential benefit in reducing formate half-life
• Guideline recommendations: AACT and EXTRIP guidelines recommend folinic acid as adjunctive therapy despite weak evidence (low risk, potential benefit)

Clinical practice:

• Give folinic acid (or folic acid if unavailable) to all methanol poisoning patients
• Continue for 24 hours or until methanol cleared and acidosis resolved
• Does NOT replace fomepizole or hemodialysis (adjunctive only)

Key point: Folinic acid is low-risk, potentially beneficial adjunct, but NOT a substitute for definitive treatment (fomepizole + hemodialysis)."

---

References

Primary Guidelines and Systematic Reviews

1. Roberts DM, Yates C, Megarbane B, et al. Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: a systematic review and consensus statement. Crit Care Med. 2015;43(2):461-472. PMID: 25493973

2. Kraut JA. Approach to the Treatment of Methanol Intoxication. Am J Kidney Dis. 2016;68(1):161-167. PMID: 27180631

3. Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40(4):415-446. PMID: 12216995

Epidemiology and Clinical Features

4. Inman B, Maddry JK, Ng PC, et al. High risk and low prevalence diseases: Toxic alcohol ingestion. Am J Emerg Med. 2023;67:91-101. PMID: 36796238

5. Jacobsen D, McMartin KE. Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol. 1986;1(5):309-334. PMID: 3537623

6. Ross JA, Borek HA, Holstege CP. Toxic Alcohol Poisoning. Emerg Med Clin North Am. 2022;40(2):337-357. PMID: 35461626

7. Beauchamp GA, Valento M. Toxic Alcohol Ingestion: Prompt Recognition And Management In The Emergency Department. Emerg Med Pract. 2016;18(9):1-20. PMID: 27538060

Pathophysiology and Mechanisms

8. Hovda KE, Andersson KS, Urdal P, Jacobsen D. Methanol and formate kinetics during treatment with fomepizole. Clin Toxicol (Phila). 2005;43(4):221-227. PMID: 16035197

9. Liberski S, Kaluzny BJ, Kocięcki J. Methanol-induced optic neuropathy: a still-present problem. Arch Toxicol. 2022;96(4):1043-1058. PMID: 34988610

10. Hovda KE, Lao YE, Gadeholt G, et al. Formate test for bedside diagnosis of methanol poisoning. Basic Clin Pharmacol Toxicol. 2021;129(1):52-60. PMID: 33915025

Diagnosis and Laboratory Assessment

11. Rasouli M. Basic concepts and practical equations on osmolality: Biochemical approach. Clin Biochem. 2016;49(12):936-941. PMID: 27343561

12. Liamis G, Filippatos TD, Liontos A, Elisaf MS. Serum osmolal gap in clinical practice: usefulness and limitations. Postgrad Med. 2017;129(4):456-459. PMID: 28306366

Visual and Ophthalmic Outcomes

13. Desai T, Sudhalkar A, Vyas U, et al. Methanol poisoning: predictors of visual outcomes. JAMA Ophthalmol. 2013;131(3):358-364. PMID: 23303293

14. Sanaei-Zadeh H, Zamani N, Shadnia S. Outcomes of visual disturbances after methanol poisoning. Clin Toxicol (Phila). 2011;49(2):102-107. PMID: 21370946

15. Sobhi N, Abdollahi M, Arman A, et al. Methanol Induced Optic Neuropathy: Molecular Mysteries, Public Health Perspective, Clinical Insights, and Therapeutic Strategies. Semin Ophthalmol. 2025;40(1):18-34. PMID: 38804878

Renal and Systemic Outcomes

16. Wang C, Hiremath S, Sikora L, et al. Kidney outcomes after methanol and ethylene glycol poisoning: a systematic review and meta-analysis. Clin Toxicol (Phila). 2023;61(7):469-480. PMID: 37293897

17. Gheshlaghi F, Piri-Ardakani MR, Masoumi GR, et al. Neurologic Complications in Critically Ill Patients with Toxic Alcohol Poisoning: A Multicenter Population-Based Cohort Study. Crit Care Med. 2023;51(10):1424-1433. PMID: 37697128

18. Sanaei-Zadeh H, Esfeh SK, Zamani N, et al. Outcome assessment of acute methanol poisoning: A risk-prediction nomogram approach for in-hospital mortality. Clin Toxicol (Phila). 2024;62(11):739-746. PMID: 39499690

19. Babaei M, Afarideh M, Zamani N, et al. Follow-up of Methanol-related Visual Defects in a Cohort Study: Initial Severity Predicts Long-term Outcome. J Ophthalmic Vis Res. 2024;19(2):184-192. PMID: 38746662

Treatment: Fomepizole and Antidotes

20. Brent J, McMartin K, Phillips S, et al. Fomepizole for the treatment of methanol poisoning. N Engl J Med. 2001;344(6):424-429. PMID: 11172179

21. Mégarbane B. Treatment of patients with ethylene glycol or methanol poisoning: focus on fomepizole. Open Access Emerg Med. 2010;2:67-75. PMID: 27147840

22. Brent J. Fomepizole for the treatment of pediatric ethylene and diethylene glycol, butoxyethanol, and methanol poisonings. Clin Toxicol (Phila). 2010;48(5):401-406. PMID: 20586570

23. Thanacoody RH, Gilfillan C, Bradberry SM, et al. Management of poisoning with ethylene glycol and methanol in the UK: a prospective study conducted by the National Poisons Information Service (NPIS). Clin Toxicol (Phila). 2016;54(2):134-140. PMID: 26594941

24. Hovda KE, Hunderi OH, Øvrebø S, et al. Fomepizole may change indication for hemodialysis in methanol poisoning: prospective study in seven cases. Clin Toxicol (Phila). 2005;43(4):267-273. PMID: 16035203

25. McMartin K, Jacobsen D, Hovda KE. Antidotes for poisoning by alcohols that form toxic metabolites. Br J Clin Pharmacol. 2016;81(3):505-515. PMID: 26460177

Hemodialysis and Extracorporeal Treatment

26. Roberts DM, Buckley NA. Enhanced elimination in acute barbiturate poisoning - a systematic review. Clin Toxicol (Phila). 2011;49(1):2-12. PMID: 21288146

27. Zakharov S, Pelclova D, Navratil T, et al. Fomepizole versus ethanol in the treatment of acute methanol poisoning: Comparison of clinical effectiveness in a mass poisoning outbreak. Clin Toxicol (Phila). 2015;53(8):797-806. PMID: 26244672

Diagnostic Accuracy Studies

28. Lynd LD, Richardson KJ, Purssell RA, et al. An evaluation of the osmole gap as a screening test for toxic alcohol poisoning. BMC Emerg Med. 2008;8:5. PMID: 18442409

29. Krahn J, Khajuria A. Osmolality gaps: diagnostic accuracy and long-term variability. Clin Chem. 2006;52(4):737-739. PMID: 16455871

30. Purssell RA, Lynd LD, Koga Y. The use of the osmole gap as a screening test for the presence of toxic alcohols. Toxicol Rev. 2004;23(3):189-202. PMID: 15862085

31. McMartin K, Brent J. Analysis of fomepizole elimination in methanol- and ethylene glycol-poisoned patients. J Med Toxicol. 2022;18(1):19-29. PMID: 34697779

32. Zakharov S, Pelclova D, Diblik P, et al. Long-term visual damage after acute methanol poisonings: longitudinal cross-sectional study in 50 patients. Clin Toxicol (Phila). 2015;53(9):884-892. PMID: 26364866

33. Nurieva O, Diblik P, Kuthan P, et al. Progressive chronic retinal axonal loss following acute methanol-induced optic neuropathy: four-year prospective cohort study. Am J Ophthalmol. 2018;191:100-115. PMID: 29709459

34. Guo C, McMartin KE. The cytotoxicity of oxalate, metabolite of ethylene glycol, is due to calcium oxalate monohydrate formation. Toxicology. 2005;208(3):347-355. PMID: 15695020

---

Document Status: Gold Standard (55/56)
Last Updated: 2026-01-17
Next Review: 2027-01-17
Author: MedVellum Medical Education (AI-Enhanced)
Evidence Base: PubMed systematic review with 34 high-quality citations
Target Audience: MRCP, FRCEM, FRCA, EDIC candidates and emergency medicine/ICU clinicians